- Home
- COLL vs NRDS Comparison
COLL vs NRDS Comparison
Compare COLL & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- NRDS
- Stock Information
- Founded
- COLL 2002
- NRDS 2009
- Country
- COLL United States
- NRDS United States
- Employees
- COLL N/A
- NRDS N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- NRDS EDP Services
- Sector
- COLL Health Care
- NRDS Technology
- Exchange
- COLL Nasdaq
- NRDS Nasdaq
- Market Cap
- COLL 958.8M
- NRDS 810.0M
- IPO Year
- COLL 2015
- NRDS 2021
- Fundamental
- Price
- COLL $30.35
- NRDS $11.32
- Analyst Decision
- COLL Strong Buy
- NRDS Buy
- Analyst Count
- COLL 4
- NRDS 6
- Target Price
- COLL $43.75
- NRDS $15.17
- AVG Volume (30 Days)
- COLL 283.6K
- NRDS 430.6K
- Earning Date
- COLL 08-07-2025
- NRDS 07-30-2025
- Dividend Yield
- COLL N/A
- NRDS N/A
- EPS Growth
- COLL N/A
- NRDS N/A
- EPS
- COLL 1.25
- NRDS 0.38
- Revenue
- COLL $664,283,000.00
- NRDS $734,900,000.00
- Revenue This Year
- COLL $20.04
- NRDS $18.07
- Revenue Next Year
- COLL $3.98
- NRDS $8.22
- P/E Ratio
- COLL $24.19
- NRDS $29.98
- Revenue Growth
- COLL 17.17
- NRDS 24.20
- 52 Week Low
- COLL $23.23
- NRDS $7.55
- 52 Week High
- COLL $42.29
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- COLL 54.25
- NRDS 61.78
- Support Level
- COLL $29.28
- NRDS $10.75
- Resistance Level
- COLL $30.83
- NRDS $11.14
- Average True Range (ATR)
- COLL 0.75
- NRDS 0.34
- MACD
- COLL -0.00
- NRDS 0.02
- Stochastic Oscillator
- COLL 51.63
- NRDS 82.45
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.